Get notified when VVOS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (worsened) — Going concern language now explicitly states 'substantial doubt' with near and long term cash requirements insufficient for next twelve months.
- Delisting (worsened) — Company received new Nasdaq deficiency notice in April 2026 for negative stockholders' equity of $1.55M, escalating from prior compliance issues.
Vivos posts 70% revenue growth from sleep services acquisition but losses double to $7.8M
Filed May 20, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 15, 2025 · ~1 min read
Key Changes
-
high
Q1 2026 revenue jumped 70% to $5.1M driven by $2.0M in new sleep testing services and $0.9M from treatment centers acquired via SCN deal, but net loss nearly doubled to $7.7M as operating expenses outpaced growth.
MD&A: Financial Results verify on EDGAR → -
high
Company received Nasdaq deficiency notice in April 2026 for negative stockholders' equity of $1.55M and is evaluating debt-to-equity restructuring of SCN acquisition debt to regain compliance.
MD&A: Nasdaq Compliance verify on EDGAR → -
high
Operating cash burn increased 58% to $6.0M in Q1 2026 from $3.8M prior year; cash position of $2.1M insufficient for next twelve months, maintaining going concern status despite $6.1M in new financing.
MD&A: Liquidity verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade VVOS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 25, 2026 · How we verify